- Home
- MCI vs SIGA Comparison
MCI vs SIGA Comparison
Compare MCI & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCI
- SIGA
- Stock Information
- Founded
- MCI 1971
- SIGA 1995
- Country
- MCI United States
- SIGA United States
- Employees
- MCI N/A
- SIGA N/A
- Industry
- MCI Trusts Except Educational Religious and Charitable
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- MCI Finance
- SIGA Health Care
- Exchange
- MCI Nasdaq
- SIGA Nasdaq
- Market Cap
- MCI 436.4M
- SIGA 422.9M
- IPO Year
- MCI N/A
- SIGA 1997
- Fundamental
- Price
- MCI $21.69
- SIGA $6.77
- Analyst Decision
- MCI
- SIGA
- Analyst Count
- MCI 0
- SIGA 0
- Target Price
- MCI N/A
- SIGA N/A
- AVG Volume (30 Days)
- MCI 40.4K
- SIGA 388.3K
- Earning Date
- MCI 01-01-0001
- SIGA 07-31-2025
- Dividend Yield
- MCI 8.46%
- SIGA 8.70%
- EPS Growth
- MCI N/A
- SIGA N/A
- EPS
- MCI 1.82
- SIGA 0.67
- Revenue
- MCI N/A
- SIGA $120,330,310.00
- Revenue This Year
- MCI N/A
- SIGA N/A
- Revenue Next Year
- MCI N/A
- SIGA $95.31
- P/E Ratio
- MCI $9.88
- SIGA $10.09
- Revenue Growth
- MCI N/A
- SIGA N/A
- 52 Week Low
- MCI $12.96
- SIGA $4.95
- 52 Week High
- MCI $19.24
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- MCI 57.60
- SIGA 61.28
- Support Level
- MCI $21.18
- SIGA $6.34
- Resistance Level
- MCI $21.97
- SIGA $7.07
- Average True Range (ATR)
- MCI 0.62
- SIGA 0.22
- MACD
- MCI -0.00
- SIGA 0.02
- Stochastic Oscillator
- MCI 70.70
- SIGA 71.70
About MCI Barings Corporate Investors
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.